Skip to main content
OpenTrials
Completed

NCT Number: NCT02413957

Medication Reconciliation in Comparison to an Extensive Medication Safety Check

The purpose of this study is to determine wether an extensive medication safety check has a greater impact on the incidence of adverse drug events than medication reconciliation or no intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elderly Adverse Drug Event Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Aachen

Aachen, 52074, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient 65 years and older
  • written informed consent patient or the legal representative
  • existing medication therapy at hospitalization
  • admission to one of the project wards via emergency department (non elective)

Exclusion criteria

  • patients included in the study previously

Treatment and study plan

Medication reconciliation

Other

Pharmacist take the best possible medication history (BPMH), comparison of the BPMH with the admission order (AMO), clarify and solve al discrepancies between the BPMH and the AMO.

Pharmaceutical care

Other

Checking medication under safety considerations (medication at admission, during hospital stay, at discharge); recommendations for inappropriate medication (e.g. contraindications or interactions) or medication related problems. Pharmaceutical care includes Medication Reconciliation.

Primary outcomes

  1. incidence of adverse drug events

    Time frame: 1 year

Secondary outcomes

  1. Assessment of the clinical relevance of medication related problems as determined by the French Society of Clinical Pharmacy

    Time frame: 1 year

    Severity scale for medication related problems: minor, significative, major, critical, catastrophic

  2. Assessment of the clinical relevance of discrepancies as determined by the French Society of Clinical Pharmacy

    Time frame: 1 year

    Severity scale for discrepancies: minor, significative, major, critical, catastrophic

  3. number of medication related problems

    Time frame: 1 year

  4. number of discrepancies

    Time frame: 1 year

  5. duration of taking the best possible medication history

    Time frame: 1 year

    The duration is measured in minutes.

Sponsors and collaborators

Lead sponsor

RWTH Aachen University

Other

Collaborators

  • Universitätsklinikum Bonn - Institut für Patientensicherheit
  • Ärztliche Zentrum für Qualität in der Medizin

Registry information

Official study title

Pilot Project to Investigate the Influence of Medication Reconciliation and an Extensive Medication Safety Check on the Number of Adverse Drug Events in the Elderly

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 10, 2015
Registry last updated
Jan 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.